Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development

References

• Kwok KO, Lai F, Wei WI, Wong SYS, Tang JWT. Herd immunity – estimating the level required to halt the COVID-19 epidemics in affected countries. J Infect. 2020 Mar 21 [accessed 2020 May 10]; 2. doi:10.1016/j.jinf.2020.03.027.
   Web of Science ®Google Scholar
• Woo PCY, Wang M, Lau SKP, Xu H, Poon RWS, Guo R, Wong BHL, Gao K, Tsoi H-W, Huang Y, et al. Comparative analysis of twelve genomes of three Novel Group 2c and Group 2d Coronaviruses reveals unique group and subgroup features. J Virol. 2007;81:1574–85. doi:10.1128/JVI.02182-06.
   PubMed Web of Science ®Google Scholar
• Dijkman R, Jebbink MF, Gaunt E, Rossen JWA, Templeton KE, Kuijpers TW, van der Hoek L. The dominance of human coronavirus OC43 and NL63 infections in infants. J Clin Virol. 2012;53:135–39. doi:10.1016/j.jcv.2011.11.011.
   PubMed Web of Science ®Google Scholar
• Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med. 1966;121:190–93. doi:10.3181/00379727-121-30734.
   PubMed Web of Science ®Google Scholar
• McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A. 1967;57:933–40. doi:10.1073/pnas.57.4.933.
   PubMed Web of Science ®Google Scholar
• van der Hoek L, Pyrc K, Jebbink MF, Vermeulen-Oost W, Berkhout RJM, Wolthers KC, Wertheim-van Dillen PME, Kaandorp J, Spaargaren J, Berkhout B. Identification of a new human coronavirus. Nat Med. 2004;10:368–73. doi:10.1038/nm1024.
   PubMed Web of Science ®Google Scholar
• Dijkman R, Jebbink MF, Idrissi NBE, Pyrc K, Muller MA, Kuijpers TW, Zaaijer HL, van der Hoek L. Human Coronavirus NL63 and 229E seroconversion in children. J Clin Microbiol. 2008;46:2368–73. doi:10.1128/JCM.00533-08.
   PubMed Web of Science ®Google Scholar
• Drosten C, Günther S, Preiser W, van der Werf S, Brodt H-R, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RAM, et al. Identification of a Novel Coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348:1967–76. doi:10.1056/NEJMoa030747.
   PubMed Web of Science ®Google Scholar
• Woo PCY, Lau SKP, Chu C-M, Chan K-H, Tsoi H-W, Huang Y, Wong BHL, Poon RWS, Cai JJ, Luk W-K, et al. Characterization and complete genome sequence of a Novel Coronavirus, Coronavirus HKU1, from patients with Pneumonia. J Virol. 2005;79:884–95. doi:10.1128/JVI.79.2.884-895.2005.
   PubMed Web of Science ®Google Scholar
• Fehr AR, Channapannavar R, Perlman S. Middle East respiratory syndrome (MERS): emergence of a pathogenic human Coronavirus. Annu Rev Med. 2017;68:387–99. doi:10.1146/annurev-med-051215-031152.
   PubMed Web of Science ®Google Scholar
• Singhal TA. Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020;87:281–86. doi:10.1007/s12098-020-03263-6.
   PubMed Web of Science ®Google Scholar
• Lim YX, Ng YL, Tam JP, Liu DX. Human Coronaviruses: a review of virus–host interactions. Diseases. 2016:4. doi:10.3390/diseases4030026.
   PubMedGoogle Scholar
• Boncristiani HF, Criado MF, Arruda E. Respiratory Viruses. Encycl Microbiol. 2009 Feb 17 [accessed 2020 May 21]; 18. doi:10.1016/B978-012373944-5.00314-X.
   Google Scholar
• Huang AT, Garcia-Carreras B, Hitchings MDT, Yang B, Katzelnick LC, Rattigan SM, Borgert BA, Moreno CA, Solomon BD, Rodriguez-Barraquer I, et al. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. medRxiv. 2020 Apr 17 [accessed 2020 May 18]; 47. doi:10.1101/2020.04.14.20065771.
   Google Scholar
• Li F. Evidence for a common evolutionary origin of coronavirus spike protein receptor-binding subunits. J Virol. 2012;86:2856–58. doi:10.1128/JVI.06882-11.
   PubMed Web of Science ®Google Scholar
• Varghese L, Zachariah P, Vargas C, LaRussa P, Demmer RT, Furuya YE, Whittier S, Reed C, Stockwell MS, Saiman L. Epidemiology and clinical features of human coronaviruses in the pediatric population. J Pediat Inf Dis Soc. 2018;7:151–58. doi:10.1093/jpids/pix027.
   PubMed Web of Science ®Google Scholar
• Stockman LJ, Massoudi MS, Helfand R, Erdman D, Siwek AM, Andersosn LJ, Parashar UD. Severe acute respiratory syndrome in children. Pediatr Infect Dis J. 2007;26:68–74. doi:10.1097/01.inf.0000247136.28950.41.
   PubMed Web of Science ®Google Scholar
• Thabet F, Chehab M, Bafaqih H, AlMohaimeed S. Middle East respiratory syndrome coronavirus in children. Saudi Med J. 2015;36:484–86. doi:10.15537/smj.2015.4.10243.
   PubMed Web of Science ®Google Scholar
• Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, Zhang W, Wang Y, Bao S, Li Y, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382:1663–65. doi:10.1056/NEJMc2005073.
   PubMed Web of Science ®Google Scholar
• Killerby ME, Biggs HM, Haynes A, Dahl RM, Mustaquim D, Gerber SI, Watson JT. Human coronavirus circulation in the United States 2014–2017. J Clin Virol. 2018;101:52–56. doi:10.1016/j.jcv.2018.01.019.
   PubMed Web of Science ®Google Scholar
• Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020 March 17 [accessed 2020 May 14]; 25. doi:10.5858/arpa.2020-0901-SA.
   Google Scholar
• Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw F-M, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211:80–90. doi:10.1093/infdis/jiu396.
   PubMed Web of Science ®Google Scholar
• Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020;323:1582–89. doi:10.1001/jama.2020.4783.
   PubMed Web of Science ®Google Scholar
• Liu STH, Lin H-M, Baine I, Wajnberg A, Gumprecht JP, Rahman F, Rodriguez D, Tandon P, Bassily-Marcus A, Bander J, et al. Convalescent plasma treatment of severe COVID-19: A matched control study. medRxiv. 2020 May 22 [accessed 2020 May 23]; 22. doi:10.1101/2020.05.20.20102236.
   Google Scholar
• Bonam SR, Kaveri SV, Sakuntabhai A, Gilardin L, Bayry J. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients. Cell Rep. 2020:1. doi:10.1016/j.xcrm.2020.100016.
   PubMed Web of Science ®Google Scholar
• Monto AS, DeJonge PM, Callear AP, Bazzi LA, Capriola SB, Malosh RE, Martin ET, Petrie JG. Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan. J Infect Dis. 2020 Apr 4 [accessed 2020 Apr 30]; 8. doi:10.1093/infdis/jiaa161.
   PubMed Web of Science ®Google Scholar
• Talbot HK, Shepherd BE, Crowe JE, Griffin MR, Edwards KM, Podsiad AB, Tollefson SJ, Wright PF, Williams JV. The pediatric burden of human Coronaviruses evaluated for twenty years. Pediatr Infect Dis J. 2009;28:682–87. doi:10.1097/INF.0b013e31819d0d27.
   PubMed Web of Science ®Google Scholar
• Paules CI, Marston HD, Fauci AS. Coronavirus infections—more than just the common cold. JAMA. 2020;323:707–08. doi:10.1001/jama.2020.0757.
   PubMed Web of Science ®Google Scholar
• Meyer B, Drosten C, Müller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus Res. 2014;194:175–83. doi:10.1016/j.virusres.2014.03.018.
   PubMed Web of Science ®Google Scholar
• Nowak MD, Sordillo EM, Gitman MR, Mondolfi AEP. Co-infection in SARS-CoV-2 infected patients: where Are Influenza Virus and Rhinovirus/Enterovirus? J Med Virol. 2020 Apr 30 [accessed 2020 May 24]; 7. doi:10.1002/jmv.25953.
   Web of Science ®Google Scholar
• Wan WY, Lim SH, Seng EH. Cross-reaction of sera from COVID-19 patients with SARS-CoV assays. medRxiv. 2020 Mar 23 [accessed 2020 May 12]; 12. doi:10.1101/2020.03.17.20034454.
   Google Scholar
• Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11:1620. doi:10.1038/s41467-020-15562-9.
   PubMed Web of Science ®Google Scholar
• Pinto D, Park Y-J, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, et al. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020 May 18;[accessed 2020 May 20]. 27. doi:10.1038/s41586-020-2349-y.
   Web of Science ®Google Scholar
• Tamburello A, Marando M. Immunoglobulins or convalescent plasma to tackle COVID-19: buying time to save lives – current situation and perspectives. Swiss Med Wkly. 2020;150:1718. doi:10.4414/smw.2020.20264.
   Web of Science ®Google Scholar
• de Assis RR, Jain A, Nakajima R, Jasinskas A, Felgner J, Obiero JM, Adenaiye O, Tai S, Hong F, Norris P, et al. Analysis of SARS-CoV-2 Antibodies in COVID-19 convalescent blood using a Coronavirus antigen microarray. medRxiv. 2020 Apr 17 [accessed 2020 May 14]; 21. doi:10.1101/2020.04.15.043364.
   Google Scholar
• Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen M-H, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 2003;300:1394–99. doi:10.1126/science.1085952.
   PubMed Web of Science ®Google Scholar
• Zhao J, Wang W, Wang W, Zhao Z, Zhang Y, Lv P, Ren F, Gao X-M. Comparison of immunoglobulin G responses to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome (SARS) Coronavirus in patients with SARS. Clin Vaccine Immunol. 2007;14:839–46. doi:10.1128/CVI.00432-06.
   PubMedGoogle Scholar
• Che X-Y, Qiu L-W, Liao Z-Y, Wang Y-D, Wen K, Pan Y-X, Hao W, Mei Y-B, Cheng VCC, Yuen K-Y. Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J Infect Dis. 2005;19:2033–37. doi:10.1086/430355.
   Google Scholar
• Centers for Disease Control and Prevention. COVIDView. Washington (DC); 2020 May 19 [accessed 2020 May 21]. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
   Google Scholar
• Gorse GJ, Donovan MM, Patel GB. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. J Med Virol. 2020;92:512–17. doi:10.1002/jmv.25715.
   PubMed Web of Science ®Google Scholar
• Fouda GG, Martinez DR, Swamy GK, Permar SR. The impact of IgG transplacental transfer on early life immunity. ImmunoHorizons. 2018;2:14–25. doi:10.4049/immunohorizons.1700057.
   PubMedGoogle Scholar